Clinical trial
Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study
NCT02081807 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 7, 2014
- Completion date
- November 1, 2017
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.